Achalasia — diagnosis & definitive management
Achalasia · Gastroenterology
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Failure of lower oesophageal sphincter relaxation with absent peristalsis from myenteric plexus degeneration, causing progressive dysphagia to solids and liquids, regurgitation and weight loss. Chicago Classification subtype guides therapy.
Red flags
- Rapid weight loss with short history and age >55 (pseudoachalasia)
- Chest pain and fever after dilatation/POEM (perforation)
- Aspiration pneumonia
- Complete inability to swallow saliva (acute retention)
Assessment
Differential diagnosis
- Pseudoachalasia (GOJ malignancy)
- Oesophageal stricture
- Diffuse oesophageal spasm / jackhammer oesophagus
- Eosinophilic oesophagitis
- Chagas disease
- Scleroderma oesophagus
Investigations
- High-resolution oesophageal manometry (diagnostic; subtype I–III)
- Endoscopy to exclude pseudoachalasia/malignancy at the GOJ
- Timed barium swallow (bird's-beak, retained column height)
- EndoFLIP (impedance planimetry) where available
- CT/EUS if pseudoachalasia suspected (age >55, rapid weight loss, short history)
Management
- Confirm with high-resolution manometry (integrated relaxation pressure elevated, absent peristalsis)
- Exclude mechanical/malignant GOJ obstruction with endoscopy ± cross-sectional imaging
- Assign Chicago subtype — type II responds best, type III favours myotomy
- Assess fitness and preference to choose definitive therapy
- Offer pneumatic balloon dilatation or laparoscopic Heller myotomy with fundoplication as durable options
- Consider per-oral endoscopic myotomy (POEM), especially for type III
- Reserve botulinum toxin injection for patients unfit for definitive therapy
- Give nutritional support and upright posture/eating advice pre-treatment
- Start PPI after myotomy/POEM given high reflux rates
- Arrange timed barium swallow and symptom (Eckardt) score to assess response
- Enrol in long-term follow-up with periodic surveillance given small oesophageal cancer risk
Drugs & doses
Botulinum toxin 100 units injected into LOS (unfit for definitive therapy)
Nifedipine 10–20 mg sublingual before meals (bridging only)
Omeprazole 20–40 mg PO once daily (post-myotomy reflux)
Disposition
Refer to specialist oesophageal/foregut unit for definitive therapy; nutrition support meanwhile.
Complications & pitfalls
- Oesophageal perforation after dilatation or myotomy
- Post-treatment gastro-oesophageal reflux
- Aspiration pneumonia
- Megaoesophagus requiring oesophagectomy
- Small long-term risk of squamous cell carcinoma
Exam pearls
- Normal endoscopy does not exclude achalasia — manometry is the key test
- Botulinum toxin is temporary (months) and best reserved for the frail/unfit
- Type III (spastic) achalasia responds better to a long myotomy via POEM than to dilatation
- Always exclude pseudoachalasia before treating, especially in older patients with weight loss
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.